Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1419-2018Class III

Cocaine Metabolite MICRO-PLATE EIA, Catalog Number: 1122SC, UDI: (0100608337000429(17)180228(10)000

OraSure Technologies, Inc. / initiated 2017-12-20 / Terminated / root cause: manufacturing process

OraSure Technologies, Inc. began a recall of Cocaine Metabolite MICRO-PLATE EIA, Catalog Number: 1122SC, UDI: (0100608337000429(17)180228(10)000 on . FDA classified it as Class III and gives the reason as "The controls and calibrators contained within the cocaine test kit may cause false positive results with the negative control". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1419-2018
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
OraSure Technologies, Inc.
Product
Cocaine Metabolite MICRO-PLATE EIA, Catalog Number: 1122SC, UDI: (0100608337000429(17)180228(10)000
Product code
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Reason for recall
The controls and calibrators contained within the cocaine test kit may cause false positive results with the negative control.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
The email to the firm's consignees states the controls will be replaced.
Quantity in commerce
10
Distribution
Distributed to 2 consignees in KS.
Product codes and lots
Lot Number: 0006661251, Expiration date: 02/28/2018

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1419-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1419-2018Class IIITerminatedVoluntary: Firm initiated